Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Hypofractionated Radiotherapy (16 Gy in 2 Fractions With an Interval of One Week) for the Palliation of Complicated Bone Metastases in Patients With Poor Performance Status

NCT02376322 is registered in ClinicalTrials.gov with Santa Casa de Porto Alegre as lead sponsor.

NCT NCT02376322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02376322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Hypofractionated Radiotherapy (16 Gy in 2 Fractions With an Interval of One Week) for the Palliation of Complicated Bone Metastases in Patients With Poor Performance Status
Lead sponsor
Santa Casa de Porto Alegre
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2014
Completion date
July 30, 2016
Enrollment
50 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases